So after the interm analysis anything longer than 3 months you would consider icing on the cake - so to speak.
Not disagreeing but why is it a "correction " only when a stock is going down? Isn't going up a "correction "too?
Now they need to track patients OS and see how closely it tracks the percentage of Triple-positive CTC cells.
It's only a day away!
OK, we've thought this for a while, now it's been published, but will it move the stock price? I hope so but EXEL seems range bound until the Comet results start coming out.
Either way nice find once again!